Engaging Patients in Real-World Evidence: An Atrial Fibrillation Patient Advisory Board Case Example

被引：0
|
作者：
Elisabeth M. Oehrlein
Xuemei Luo
Mirko Savone
Trudie Lobban
Amiee Kang
Brian Lee
Rex Gale
Silke Schoch
Eleanor Perfetto
机构：
[1] National Health Council,Department Pharmaceutical Health Services Research
[2] Pfizer,undefined
[3] Inc,undefined
[4] Health Economics and Outcomes Research,undefined
[5] Pfizer,undefined
[6] Inc.,undefined
[7] Heart Rhythm Alliance,undefined
[8] Arrhythmia Alliance,undefined
[9] Bristol-Myers Squibb Company,undefined
[10] Board Member-Arrhythmia Alliance,undefined
[11] University of Maryland Baltimore,undefined
来源：
The Patient - Patient-Centered Outcomes Research | 2021年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：295 / 300
页数：5
相关论文
共 50 条
  • [31] REVERSAL AGENTS IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS HOSPITALIZED FOR BLEEDING: A REAL-WORLD ANALYSIS
    Robinson, Scott
    Bowdy, Bruce D.
    Jing, Yonghua
    Schaiff, Robyn
    Lee, Veronica
    McMahon, Ellen
    Johnson, Bernadette H.
    Wiederkehr, Daniel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A419 - A419
  • [32] Real-World Antithrombotic Therapy in Atrial Fibrillation Patients with a History of Percutaneous Coronary Intervention
    Horiguchi, Ai
    Fukaya, Hidehira
    Oikawa, Jun
    Shirakawa, Yuki
    Kobayashi, Shuhei
    Arakawa, Yuki
    Nishinarita, Ryo
    Nakamura, Hironori
    Ishizue, Naruya
    Igarashi, Gen
    Satoh, Akira
    Kishihara, Jun
    Niwano, Shinichi
    Ako, Junya
    INTERNATIONAL HEART JOURNAL, 2019, 60 (06) : 1321 - 1327
  • [33] Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
    Gustafson, Whitney L.
    Saunders, John
    Vazquez, Sara R.
    Jones, Aubrey E.
    Witt, Daniel M.
    PHARMACY PRACTICE-GRANADA, 2019, 17 (04):
  • [34] Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real-World Data
    Buckley, Benjamin J. R.
    Harrison, Stephanie L.
    Gupta, Dhiraj
    Fazio-Eynullayeva, Elnara
    Underhill, Paula
    Lip, Gregory Y. H.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (23):
  • [35] Real-World Risk of Thromboembolism or Bleeding with Warfarin or Dabigatran Therapy in Patients with Atrial Fibrillation
    Charland, Scott I.
    Malone, Daniel C.
    Agatep, Barnabie C.
    Herrera, Vivian
    Hawk, Gosia S.
    Schrader, Bruce J.
    Stanek, Eric J.
    CIRCULATION, 2012, 126 (21)
  • [36] Real-World Comparative Effectiveness and Safety of Rivaroxaban and Warfarin in Nonvalvular Atrial Fibrillation Patients
    Laliberte, Francois
    Cloutier, Michel
    Nelson, Winnie W.
    Coleman, Craig I.
    Duh, Mei Sheng
    Pilon, Dominic
    Damaraju, C. V.
    Schein, Jeffrey R.
    Lefebvre, Patrick
    CIRCULATION, 2013, 128 (22)
  • [37] New Direct Oral Anticoagulants for Treatment of Patients with Atrial Fibrillation in Real-World Setting
    Kobalava, Zhanna D.
    Villevalde, Svetlana V.
    Shavarov, Andrey A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2018, 14 (02) : 298 - 305
  • [38] Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure
    Yang, Pil-Sung
    Kim, Daehoon
    Sung, Jung-Hoon
    Jang, Eunsun
    Yu, Hee Tae
    Kim, Tae-Hoon
    Uhm, Jae-Sun
    Kim, Jong-Youn
    Pak, Hui-Nam
    Lee, Moon-Hyoung
    Joung, Boyoung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [39] REAL-WORLD COMPARATIVE EFFECTIVENESS AND SAFETY OF RIVAROXABAN AND WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS
    Laliberte, F.
    Cloutier, M.
    Nelson, W. W.
    Coleman, C., I
    Pilon, D.
    Olson, W. H.
    Damaraju, C., V
    Schein, J. R.
    Lefebvre, P.
    VALUE IN HEALTH, 2014, 17 (03) : A102 - A103
  • [40] The management of anticoagulant treatment in non-valvular atrial fibrillation real-world patients
    Valeriani, Emanuele
    Ageno, Walter
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 62 : 7 - 8
12345